BeStock  
Stocks › Biotechnology › CRMD

CorMedix CRMD

US equityMarket cap rank #3659Biotechnology
$5.27 +$0.19 (+3.74%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.32 +0.95%
Open$4.96
Prev close$5.08
Day range$4.95 – $5.32
Volume3.61M
Market cap$419.16M
P/E (TTM)8.2
Dividend yield–

CRMD Stock News

Headlines matching CorMedix or the CRMD ticker, most recent first.

  • Analysts Are Bullish on Top Healthcare Stocks: Parabilis Medicines, Inc. (PBLS), Cormedix (CRMD) PositiveTipRanks · 14 Aug 2026 · Direct mention
  • Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $15Market news · 14 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13Market news · 14 Aug 2026 · Direct mention
  • RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $14 PositiveMarket news · 14 Aug 2026 · Direct mention
  • RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13 NegativeMarket news · 7 Jul 2026 · Direct mention
  • Truist Financial Maintains CorMedix(CRMD.US) With Buy RatingMarket news · 15 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for CorMedix(CRMD.US), With a Forecast Between $13 to $15Market news · 15 May 2026 · Direct mention
  • RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13Market news · 9 Apr 2026 · Direct mention
  • Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $14Market news · 15 Apr 2026 · Direct mention
  • Leerink Partners Maintains CorMedix(CRMD.US) With Buy Rating, Announces Target Price $13Market news · 7 Mar 2026 · Direct mention
  • Needham Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $14 NegativeMarket news · 6 Mar 2026 · Direct mention
  • Analysts' Top Healthcare Picks: Cormedix (CRMD), CG Oncology, Inc. (CGON)TipRanks · 4 Feb 2026 · Direct mention
  • Oppenheimer Maintains CorMedix(CRMD.US) With Buy Rating, Announces Target Price $13Market news · 13 Nov 2026 · Direct mention
  • RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $14 NegativeMarket news · 13 Nov 2026 · Direct mention
  • H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13Market news · 13 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on CRMD.

Sign in to join the discussion.

Scroll to Top